Related references
Note: Only part of the references are listed.A Plasmodium vivax experimental human infection model for evaluating efficacy of interventions
Katharine A. Collins et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
Tafenoquine: the new kid on the block
Victor Chen et al.
CURRENT OPINION IN INFECTIOUS DISEASES (2019)
The Dynamics of Liver Function Test Abnormalities after Malaria Infection: A Retrospective Observational Study
John Woodford et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2018)
Assessing Plasmodium falciparum transmission in mosquito-feeding assays using quantitative PCR
Claire Y. T. Wang et al.
MALARIA JOURNAL (2018)
Safety, tolerability, pharmacokinetics, and activity of the novel long-acting antimalarial DSM265: a two-part first-in-human phase 1a/1b randomised study
James S. McCarthy et al.
LANCET INFECTIOUS DISEASES (2017)
Malaria
Margaret A. Phillips et al.
NATURE REVIEWS DISEASE PRIMERS (2017)
Attacking Plasmodium vivax
J. Kevin Baird
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2016)
Key Knowledge Gaps for Plasmodium vivax Control and Elimination
Quique Bassat et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2016)
Global Epidemiology of Plasmodium vivax
Rosalind E. Howes et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2016)
Efficacy of OZ439 (artefenomel) against early Plasmodium falciparum blood-stage malaria infection in healthy volunteers
James S. McCarthy et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2016)
Antimalarial activity of artefenomel (OZ439), a novel synthetic antimalarial endoperoxide, in patients with Plasmodium falciparum and Plasmodium vivax malaria: an open-label phase 2 trial
Aung Pyae Phyo et al.
LANCET INFECTIOUS DISEASES (2016)
A Phase II pilot trial to evaluate safety and efficacy of ferroquine against early Plasmodium falciparum in an induced blood-stage malaria infection study
James S. McCarthy et al.
MALARIA JOURNAL (2016)
Safety and Reproducibility of a Clinical Trial System Using Induced Blood Stage Plasmodium vivax Infection and Its Potential as a Model to Evaluate Malaria Transmission
Paul Griffin et al.
PLOS NEGLECTED TROPICAL DISEASES (2016)
Evaluating the Pharmacodynamic Effect of Antimalarial Drugs in Clinical Trials by Quantitative PCR
Louise Marquart et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Global extent of chloroquine-resistant Plasmodium vivax: a systematic review and meta-analysis
Ric N. Price et al.
LANCET INFECTIOUS DISEASES (2014)
Comparison of three methods for detection of gametocytes in Melanesian children treated for uncomplicated malaria
Stephan Karl et al.
MALARIA JOURNAL (2014)
First-in-man safety and pharmacokinetics of synthetic ozonide OZ439 demonstrates an improved exposure profile relative to other peroxide antimalarials
Joerg J. Moehrle et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2013)
Experimentally Induced Blood-Stage Plasmodium vivax Infection in Healthy Volunteers
James S. McCarthy et al.
JOURNAL OF INFECTIOUS DISEASES (2013)
Comparative Ex Vivo Activity of Novel Endoperoxides in Multidrug-Resistant Plasmodium falciparum and P. vivax
Jutta Marfurt et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Synthetic ozonide drug candidate OZ439 offers new hope for a single-dose cure of uncomplicated malaria
Susan A. Charman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Vivax malaria: Neglected and not benign
Ric N. Price et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2007)
Share Paper
